Gilead says remdesivir reduced risk of death in Covid-19 patients, more studies neededThe company, which had initially released the data from the trial in April, said the finding requires confirmation in clinical trialsLatest UpdatesCOVID-19 Updates By Reuters On Jul 11, 2020 0 3,868 Share
